Rhythm Pharmaceuticals, Inc. (RYTM)
103.38
-0.23
(-0.22%)
USD |
NASDAQ |
Feb 09, 15:05
Rhythm Pharmaceuticals EPS Diluted (Quarterly) : -0.8192 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Geron Corp. | -0.0276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.90M |
| Revenue (Quarterly) | 51.30M |
| Total Expenses (Quarterly) | 104.20M |
| Enterprise Value | 6.758B |
| Gross Profit Margin (Quarterly) | 89.08% |
| Profit Margin (Quarterly) | -103.1% |
| Earnings Yield | -3.00% |
| Normalized Earnings Yield | -2.992 |